164 related articles for article (PubMed ID: 37637962)
1. Rhes depletion promotes striatal accumulation and aggregation of mutant huntingtin in a presymptomatic HD mouse model.
Pan Y; Tang B; Li XJ; Li S; Liu Q
Front Aging Neurosci; 2023; 15():1237018. PubMed ID: 37637962
[TBL] [Abstract][Full Text] [Related]
2. Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease.
Swarnkar S; Chen Y; Pryor WM; Shahani N; Page DT; Subramaniam S
Neurobiol Dis; 2015 Oct; 82():66-77. PubMed ID: 26048156
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy.
Carbo M; Brandi V; Pascarella G; Staid DS; Colotti G; Polticelli F; Ilari A; Morea V
Int J Mol Med; 2019 Dec; 44(6):2223-2233. PubMed ID: 31638189
[TBL] [Abstract][Full Text] [Related]
4. Striatal Induction and Spread of the Huntington's Disease Protein: A Novel Rhes Route.
Subramaniam S
J Huntingtons Dis; 2022; 11(3):281-290. PubMed ID: 35871361
[TBL] [Abstract][Full Text] [Related]
5. Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum).
Subramaniam S; Snyder SH
Neuropharmacology; 2011 Jun; 60(7-8):1187-92. PubMed ID: 21044641
[TBL] [Abstract][Full Text] [Related]
6. Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy.
Mealer RG; Murray AJ; Shahani N; Subramaniam S; Snyder SH
J Biol Chem; 2014 Feb; 289(6):3547-54. PubMed ID: 24324270
[TBL] [Abstract][Full Text] [Related]
7. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
[TBL] [Abstract][Full Text] [Related]
8. Loss of Hap1 selectively promotes striatal degeneration in Huntington disease mice.
Liu Q; Cheng S; Yang H; Zhu L; Pan Y; Jing L; Tang B; Li S; Li XJ
Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20265-20273. PubMed ID: 32747555
[TBL] [Abstract][Full Text] [Related]
9. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
[TBL] [Abstract][Full Text] [Related]
10. The role of Rhes, Ras homolog enriched in striatum, in neurodegenerative processes.
Harrison LM; Lahoste GJ
Exp Cell Res; 2013 Sep; 319(15):2310-5. PubMed ID: 23583659
[TBL] [Abstract][Full Text] [Related]
11. Autophagy Activation by Transcription Factor EB (TFEB) in Striatum of HDQ175/Q7 Mice.
Vodicka P; Chase K; Iuliano M; Tousley A; Valentine DT; Sapp E; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
J Huntingtons Dis; 2016 Oct; 5(3):249-260. PubMed ID: 27689619
[TBL] [Abstract][Full Text] [Related]
12. Rhes protein transits from neuron to neuron and facilitates mutant huntingtin spreading in the brain.
Ramírez-Jarquín UN; Sharma M; Shahani N; Li Y; Boregowda S; Subramaniam S
Sci Adv; 2022 Mar; 8(12):eabm3877. PubMed ID: 35319973
[TBL] [Abstract][Full Text] [Related]
13. Curbing Rhes Actions: Mechanism-based Molecular Target for Huntington's Disease and Tauopathies.
Subramaniam S; Boregowda S
CNS Neurol Disord Drug Targets; 2024; 23(1):21-29. PubMed ID: 36959146
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease.
Baiamonte BA; Lee FA; Brewer ST; Spano D; LaHoste GJ
PLoS One; 2013; 8(1):e53606. PubMed ID: 23349722
[TBL] [Abstract][Full Text] [Related]
15. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
Lu B; Palacino J
FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
[TBL] [Abstract][Full Text] [Related]
16. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity.
Subramaniam S; Sixt KM; Barrow R; Snyder SH
Science; 2009 Jun; 324(5932):1327-30. PubMed ID: 19498170
[TBL] [Abstract][Full Text] [Related]
17. RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum.
Shahani N; Swarnkar S; Giovinazzo V; Morgenweck J; Bohn LM; Scharager-Tapia C; Pascal B; Martinez-Acedo P; Khare K; Subramaniam S
Sci Signal; 2016 Nov; 9(454):ra111. PubMed ID: 27902448
[TBL] [Abstract][Full Text] [Related]
18. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
Hong Y; Zhao T; Li XJ; Li S
J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
[TBL] [Abstract][Full Text] [Related]
19. Rhes: a GTP-binding protein integral to striatal physiology and pathology.
Harrison LM
Cell Mol Neurobiol; 2012 Aug; 32(6):907-18. PubMed ID: 22450871
[TBL] [Abstract][Full Text] [Related]
20. Rhes travels from cell to cell and transports Huntington disease protein via TNT-like protrusion.
Sharma M; Subramaniam S
J Cell Biol; 2019 Jun; 218(6):1972-1993. PubMed ID: 31076452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
